China
Macquarie hires 3i’s Paul Su in China
Macquarie Capital has named Paul Su, former senior director at 3i Group, as senior managing director and chairman for Greater China.
Infrastructure fundraising: A beast with two heads
At one end of the market large institutional investors are looking to access Asian infrastructure through separate accounts or independently; at the other, plenty of LPs are still looking to make fund commitments
Q&A: Standard Chartered Bank's Andrew Yee
Andrew Yee, global head of infrastructure at Standard Chartered Bank's principal finance division, gives his views on investment opportunities across Asia, where private equity must work in and around large corporates
China cleantech: Addressing overcapacity
China's cleantech sector was the factory to the world, churning out solar panels and wind turbines for export. After the bottom fell out of the market, domestic demand took center stage - how is PE responding?
The Asia real assets story
It is difficult to tell whether Asia is at the beginning of a real assets story or negotiating a transition phase somewhere around the middle. "Real assets" is such an all-encompassing term, taking in everything from forestry to energy to real estate,...
MSPEA-backed privatization of Yongye wins board approval
A $339 million management buyout offer for Yongye International, supported by Morgan Stanley Private Equity Asia (MSPEA), has won board approval. The US-listed Chinese animal and plant feed maker is now set to be taken private, pending a shareholder vote.
KKR, CDH invest in $140m China dairy farm joint venture
KKR has completed its first majority investment in China, partnering with CDH Investments and China Modern Dairy in a $140 million greenfield farming joint venture that will deliver premium raw milk to domestic consumers.
Sequoia leads Series B round for China second-hand car platform
Sequoia Capital led a Series B round of investment for Souche Holdings, an online second-hand car trading platform. Existing backers Morningside Technologies and Ferry Venture Capital also participated.
IDG invests in Chinese personal finance app developer
IDG Capital Partners has provided a Series A round of funding for Hangzhou Wacai Science, a Chinese personal finance management mobile app developer. Terms of transaction was undisclosed but the investment was said to be more than $10 million.
Hony still committed to China SOE restructuring, more focused on value creation
Hony Capital has pledged to remain a China-focused investor despite the country’s slowing economic growth and forays by other private equity firms into new markets in order to diversify risk. Hony’s emphasis will be on value creation, particularly...
China Private Equity Investment exits AIP Global to Capital VC
China Private Equity Investment Holdings (CPE) has agreed to sell its entire holding of 2.45% in AIP Global, a Hong Kong-based investment holding company that focuses on the financial sector, to Capital VC for HK$15 million ($19 million).
Profile: AIF Capital's Peter Amour
Since arriving in Hong Kong in 1986, AIF Capital's Peter Amour has witnessed the emergence of China and the ups and downs of Southeast Asia, enjoying some of the opportunities that have come with it
CRCI reaches $180m first close on Fund III
China Renaissance Capital Investment (CRCI) has reached a first close of approximately $180 million on its third growth capital fund. The timing of the close was determined by the GP needing to finalize its first investment out of the new vehicle.
Warburg Pincus invests in China health center Amcare
Warburg Pincus has invested in Beijing-based Amcare Women's & Children's Hospital. The transaction size was not disclosed.
Investors book passage with Tuniu
Most Travel e-commerce companies in China are essentially search engines that provide information on hotel and flight bookings plus a payment mechanism. The team at Tuniu opted for a different tack, focusing specifically on packaged tourism, and they...
ClearVue Partners backs $5m round for China online grocery store
ClearVue Partners has led a $5 million Series A round of funding in Shanghai-based online grocery store Fields.
Niche funds: Finding an angle
China has seen a proliferation of niche funds in recent years as GPs try to stand out from the crowd with differentiated strategies. Are investors – institutions, individuals or governments – buying into the story?
Axa-owned Novacap chemicals group makes China acquisition
AXA Private Equity-backed French chemicals group Novacap, is to acquire a majority stake in Taixing Yangzi Pharm Chemical (Yangzi), one of the leading Chinese producers of a chemical mainly used for the production of paracetamol. Financial terms of the...
VC-backed Forgame targets $222m Hong Kong IPO
Forgame Holdings, a Guangzhou-based mobile game developer backed by several VC firms, plans to raise at least $222 million through an IPO in Hong Kong.
GGV invests in China LED producer's pre-IPO round
GGV Capital has made a pre-IPO investment in Sichuan Sunfor Light, a Chinese light emitting diode (LED) manufacturer. Terms of transaction were not disclosed.
Chinese authorities detain ex-CDH executive Gongquan Wang
Gongquan Wang, founder of CDH Venture Capital, has been detained by Chinese authorities for alleged involvement of New Citizen’s Movement, a civil rights group advocating greater transparency in government. Wang left CDH two years ago.
Temasek unit plans $185m Youku Tudou sell down – report
Sennett Investments, an affiliate of Temasek Holdings, has reportedly sold down its entire stake in Youku Tudou, an US-listed Chinese video site, generating up to S$235 million ($185 million).
KKR's Kravis bullish on Asia private equity, credit
Henry Kravis, co-founder of KKR, believes that Asia’s macro headwinds have created an attractive environment for private equity investment, although the asset class is just one of several strategies that feature in his longer-term outlook for the development...
WuXi PharmaTech-backed Foundation Medicine sets terms for $75m IPO
US cancer diagnostics firm Foundation Medicine, which counts the corporate venture fund of Shanghai-headquarted WuXi PharmaTech among its backers, has announced the terms for its US IPO.